The novel approach of the medication represents a significant development in the handling of type 2 diabetes. Different to existing medications, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide295940.bloggin-ads.com/65245451/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment